Summary
In order to investigate the anti-cancer effects of deguelin and on K562 and K562/ADM cells in vitro and the underlying molecular mechanism and compare the cytotoxicity of deguelin on K562, K562/ADM cells and human peripheral blood mononuclear cells (PBMCs). The effects of deguelin on cell proliferation were assessed by MTT assay. Apoptosis were detected by Annexin V/PI double-labeled cytometry. The effects of deguelin on the cell cycle were studied by a propidium iodide method. Our study showed that deguelin inhibited the proliferation of K562 cell and K562/ADM cell in a time- and dose-dependent manner and had minimal effects on normal human peripheral blood mononuclear cells. The ratio of IC50 value of deguelin of 24 h on K562/ADM cells to K562 cells was only 1.27, which was significantly lower than the ratio of IC50 value of ADM (higher than 20). Deguelin could induce apoptosis of K562 cells and K562/ADM cells. K562 cells were arrested at G2/M phase while K562/ADM cells were arrested at G0/G1 phase. Our results suggested that deguelin was a novel anti-leukemia agents with high efficacy and low toxicity and it is also a promising agent for reversing drug resistance.
Similar content being viewed by others
References
McWilliams A, Lam S. New approaches to lung cancer prevention. Curr Oncol Rep, 2002,4:487–94
Anderson W F, Umar A, Viner J L et al. The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des, 2002,8:1035–62
van Sanwijk N, Dalesio O, Pastorino U et al. EURO-SCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst, 2000, 92:977–86
Lippman S M, Spitz M R. Lung cancer chemoprevention: an integrated approach. J Clin Oncol, 2001,19(18 Suppl):74S–82S
Pendyala L, Schwartz G, Bolanowska-Higdon W et al. Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicity. Cancer Epidemiol Biomarkers Prev, 2001,10:269–72
Greenwald P. Cancer prevention clinical trials. J Clin Oncol, 2002,20(18 Suppl):14S–22S
Chun K H, Kosmeder J W, Sun S et al. Effect of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst, 2003,95:291–302
Liu H L, Chen Y, Cui GH et al. Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt’s lymphoma Daudi cells in vitro. Acta Pharmacologica Sinica, 2005,26(7):873–880
Murillo G, Salti G I, Kosmeder J W 2nd et al. Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. Eur J Cancer, 2002,38:2446–2454
Udeani G O, Gerhauser C, Thomas C F et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Res, 1997,57(16):3424–3428
Benner S E, Lippman S M, Hong W K. Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res, 1992,52(9 Suppl):2758s–2763
Rao C V, Rivenson A, Simi B et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res, 1995,55:259–266
Udeani G O, Zhao G M, Shin Y G et al. Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats. Gancer Chemother Pharmacol, 2001,47:263–268
Fang N, Casida J E. Anticancer action of cube insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities. Proc Natl Acad Sci USA, 1998,95(7):3380–3384
Mehta R G, Pezzuto J M. Discovery of cancer preventive agents from natural products:from plants to prevention. Curr Oncol Rep, 2002,4(6):478–486
Holleman A, den Boer M L, Kazemier K M et al. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood, 2005, 106(5):1817–1823
Author information
Authors and Affiliations
Corresponding author
Additional information
WU Qiuling, female, born in 1975, Attending Physician
This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30472267).
Rights and permissions
About this article
Cite this article
Wu, Q., Chen, Y., Liu, H. et al. Anti-cancer effects of deguelin on human leukemia K562 and K562/ADM cells In Vitro . J. Huazhong Univ. Sc. Technol. 27, 149–152 (2007). https://doi.org/10.1007/s11596-007-0210-2
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0210-2